Nova Leap Health Past Earnings Performance
Past criteria checks 0/6
Nova Leap Health's earnings have been declining at an average annual rate of -18.2%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 11.1% per year.
Key information
-18.2%
Earnings growth rate
-14.4%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 11.1% |
| Return on equity | -2.5% |
| Net Margin | -1.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Nova Leap Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 26 | 0 | 8 | 0 |
| 30 Jun 24 | 26 | 0 | 8 | 0 |
| 31 Mar 24 | 26 | 0 | 8 | 0 |
| 31 Dec 23 | 26 | -1 | 8 | 0 |
| 30 Sep 23 | 26 | -1 | 9 | 0 |
| 30 Jun 23 | 27 | -1 | 9 | 0 |
| 31 Mar 23 | 27 | -1 | 9 | 0 |
| 31 Dec 22 | 28 | -1 | 10 | 0 |
| 30 Sep 22 | 27 | -1 | 9 | 0 |
| 30 Jun 22 | 25 | 0 | 9 | 0 |
| 31 Mar 22 | 24 | 0 | 8 | 0 |
| 31 Dec 21 | 21 | 2 | 8 | 0 |
| 30 Sep 21 | 20 | 4 | 7 | 0 |
| 30 Jun 21 | 19 | 3 | 7 | 0 |
| 31 Mar 21 | 18 | 2 | 6 | 0 |
| 31 Dec 20 | 17 | 1 | 6 | 0 |
| 30 Sep 20 | 18 | 0 | 6 | 0 |
| 30 Jun 20 | 18 | -1 | 5 | 0 |
| 31 Mar 20 | 18 | 0 | 5 | 0 |
| 31 Dec 19 | 17 | -1 | 5 | 0 |
| 30 Sep 19 | 16 | -1 | 5 | 0 |
| 30 Jun 19 | 15 | -1 | 5 | 0 |
| 31 Mar 19 | 13 | -1 | 4 | 0 |
| 31 Dec 18 | 10 | -1 | 4 | 0 |
| 30 Sep 18 | 7 | -1 | 3 | 0 |
| 30 Jun 18 | 5 | -1 | 2 | 0 |
| 31 Mar 18 | 2 | -1 | 2 | 0 |
| 31 Dec 17 | 1 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
| 31 Oct 16 | 0 | 0 | 0 | 0 |
Quality Earnings: NVLP.F is currently unprofitable.
Growing Profit Margin: NVLP.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NVLP.F is unprofitable, and losses have increased over the past 5 years at a rate of 18.2% per year.
Accelerating Growth: Unable to compare NVLP.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NVLP.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: NVLP.F has a negative Return on Equity (-2.51%), as it is currently unprofitable.